1. Excess branched-chain amino acids alter myotube metabolism and substrate preference which is worsened by concurrent insulin resistance
- Author
-
Roger A. Vaughan, Caroline N Rivera, and Madison E. Rivera
- Subjects
medicine.medical_specialty ,biology ,Chemistry ,Endocrinology, Diabetes and Metabolism ,ATP5B ,Insulin ,medicine.medical_treatment ,Muscle Fibers, Skeletal ,Metabolism ,medicine.disease ,Endocrinology ,Insulin resistance ,Mitochondrial biogenesis ,Leucine ,Internal medicine ,medicine ,biology.protein ,Humans ,PPARGC1A ,Insulin Resistance ,Amino Acids, Branched-Chain ,GLUT4 - Abstract
Purpose Branched-chain amino acids (BCAA) have been shown to enhance several cellular signaling pathways including protein synthesis and mitochondrial biogenesis, yet population data demonstrate a correlation between circulating BCAA and severity of insulin resistance which has been hypothesized to be, in part, a byproduct of BCAA inhibition of mitochondrial function. The purpose of this study is to examine the effect of a BCAA mixture on muscle metabolism and related gene expression in vitro. Methods C2C12 myotubes were treated with a BCAA mixture containing leucine:isoleucine:valine at a ratio of 2:1:1 at 0.2, 2, or 20 mM (based on leucine content) for 6 days. qRT-PCR was used to measure metabolic gene expression. Oxygen consumption and extracellular acidification were used to assess mitochondrial and glycolytic metabolism, respectively. Mitochondrial content was determined via mitochondrial-specific staining. Results Despite significantly elevated mitochondrial staining, 6-day BCAA treatment reduced basal mitochondrial metabolism at a supraphysiological concentration (20 mM) in both insulin sensitive and resistant cells. Peak mitochondrial capacity was also reduced in insulin-resistant (but not insulin sensitive) cells. Conversely, basal glycolytic metabolism was elevated following 20 mM BCAA treatment, regardless of insulin resistance. In addition, insulin-resistant cells treated with 20 mM BCAA exhibited reduced gene expression of Ppargc1a, Cytc, Atp5b, Glut4, and several glycolytic enzymes versus insulin sensitive cells treated with 20 mM BCAA. Conclusions Collectively, these findings suggest BCAA at supraphysiologically high levels may negatively alter mitochondrial metabolism, and concurrent insulin resistance may also diminish peak mitochondrial capacity, as well as impede molecular adaptations that support a transition to a glycolytic preference/compensation.
- Published
- 2021
- Full Text
- View/download PDF